Search page

A dose ranging study of sting challenge and specific lgE, IgG4, venom skin test and basophil activation responses to ant venom immunotherapy with and without delta-inulin adjuvant

A positive conjunctival allergen challenge is more common in allergic rhinitis patients with conjunctivitis than in local allergic rhinitis individuals with conjunctivitis

Abatacept to induce remission of peanut allergy during oral immunotherapy (ATARI trial): baseline peanut-specific T cell responses of participants

Absence of alpha-tryptase isoforms is associated with less severe allergic reactions at food challenge to peanut

Absence of early exposure to dietary antigens impairs the host capacity to establish oral tolerance to food proteins

Adult-onset food protein-induced enterocolitis syndrome. Cytokine variations after positive oral food challenges

Advances in Oral Immunotherapy

Allergen metabolism by human oral bacteria alters its allergenicity

Allergen specific IgE is a stronger predictor of remission following Peanut Oral Immunotherapy in children aged 1-10 years

Allergic asthma – a challenge no more

Analysis of DNA repair capacity of peripheral blood lymphocytes from asthmatic patients treated with oral corticosteroids

Analysis of epinephrine use during peanut (Arachis hypogaea) allergen powder-dnfp oral immunotherapy in individuals with peanut allergy aged 1 to 3 years

Analysis of patients undergoing metronidazole challenge testing: a real-life data

Antioxidant pine nut protein hydrolysate as a therapeutic oral immunotherapy agent in a murine model of pine nut allergy

Application Study on the prevention and treatment of spleen aminopeptide oral solution on seasonal allergic rhinitis

Are LADDERS the new Oral Food Challenge?

Are oral food challenges still necessary for diagnosing food allergy

Assessing protocol variability for FPIES oral food challenges

Assessment of challenge outcomes for children with a non-beta lactam antibiotic allergy

Audit of Peanut Allergy Patients Eligible for Oral Immunotherapy (OIT) in a Paediatric Cohort at Galway University Hospital (2020-2023)

B Cell Repertoires and Phenotypes in Food Allergy and Oral Immunotherapy

Basophil activation test as a marker of desensitization in Very Low-Dose Multi-Nut Immunotherapy and Very Low-Dose Peanut Oral Immunotherapy

Biologicals as adds on in oral immunotherapy for IgE mediated food allergy

Boiled peanut or roasted peanut for oral immunotherapy: Results from the BOPI-2 Study

CHAPTER-3 Phase 3 Trial Design: Efficacy and Safety of the Oral Bradykinin B2 Receptor Antagonist Deucrictibant Extended-Release Tablet for Prophylaxis of Hereditary Angioedema Attacks

Can symptoms in Alternaria allergy be linked with objective diagnostic criteria? From intranasal allergen challenge to IgE and basophil activation test

Challenge accepted: Results from the pivotal Grass Phase III clinical trial

Chamber challenge

Changes in IgG4 and IgE epitope binding profile are greater with sublingual than oral immunotherapy in milk-allergic children, and correspond to efficacy outcomes

Changes in small airway physiology measured by impulse oscillometry in subjects with allergic asthma following methacholine and inhaled allergen challenge

Characterization of adaptative immune cells after double-blind placebo-controlled oral food challenges

Commercial product for oral food challenges: CON

Commercial product for oral food challenges: PRO

Conjunctival allergen challenge

Correlation between subjective and objective parameters in house dust mite nasal allergen challenge

Cow Milk Oral Immunotherapy: A Single-Center Experience

Decreased frequency and severity of oral immunotherapy induced gastrointestinal eosinophilic reactions following revisions in treatment protocol

Descriptive Study on the Evolution of Patients Treated with Oral Immunotherapy (OIT) Using Pasteurized Egg White at the Fundación Alcorcón University Hospital

Descriptive study of the evolution of patients after oral immunotherapy with milk at the Hospital Universitario Fundación Alcorcón

Development of Eosinophilic Esophagitis in a Child with Multiple Food Allergies: The Role of Omalizumab, Oral Immunotherapy and Dietary Incompliance: A Case Report

Diagnostic performance of IgE sensitization with Blomia tropicalis for prediction of positive nasal challenge test

Dietary outcomes following oral immunotherapy for cows milk allergy: Results from the SOCMA Study

Direct oral provocation in adults (without skin testing first)

Do we need commercial products for oral food challenges?

EUROBAT ORAL ABSTRACT SESSION

Effect of non-specific Lipid Transfer Protein (nsLTP) allergies in oral and gut epithelial barrier integrity

Efficacy and Safety of Oral Deucrictibant, a Potent Bradykinin B2 Receptor Antagonist, in Prophylaxis of Hereditary Angioedema Attacks: Results of CHAPTER-1 Phase 2 Trial

Efficacy and Safety of the Oral Bradykinin B2 Receptor Antagonist Deucrictibant Immediate-Release Capsule in Treatment of Hereditary Angioedema Attacks: RAPIDe-3 Phase 3 Trial Design

Efficacy of two years of treatment with anti-IL-5/R therapy for reduction in use of oral glucocorticoids in patients with eosinophilic granulomatosis with polyangiitis

Evaluation of Direct Oral Provocation Test Results in Mild Cutaneous Reactions to Cephalosporins in Children

Evaluation of sustained unresponsiveness in children with IgE-Mediated Allergy to Cow’s Milk Proteins Trough Oral Tolerance Induction Protocols

Evaluation of the IgEs amount and basophil activity changes during walnut oral immunotherapy

Evaluation of the Safety of Mixed Tree Nut Oral Food Challenges in the Management of Tree Nut Allergy

Evolution of atopic keratoconjunctivitis in patients with severe to moderate atopic dermatitis treated with oral Janus kinase inhibitors

Evolution of pediatric patients with casein-specific IgE values>100 KU/L undergoing cow’s milk oral immunotherapy

Exposure-adjusted safety of peanut (Arachis hypogaea) allergen powder-dnfp oral immunotherapy in individuals with peanut allergy aged 1-3 years (POSEIDON trial)

FRIENDLY TREE NUT AND SESAME ORAL IMMUNOTHERAPY PROTOCOTOLS (ALPEDIA-NOITs)

Factors affecting the outcome of Oral Food Challenges in children

First-line anti-tuberculosis drug challenge reactions in DRESS in an HIV endemic setting

Fixed-Dose Oral Immunotherapy for High-Threshold Food Allergy: Efficacy and Safety in Real-World Practice

Flexible and Safe Oral Immunotherapy (OIT) Regimen Using Home Boiled Nut Broths (HBNB)

Food oral immunotherapy monitoring with OITcontrol® is related to reduced number of home adverse reactions and better treatment compliance compared with paper-based monitoring

From angioedema to Kimura disease: Diagnostic challenge

Giving birth to a food allergen: from oral tolerance to the epithelial barrier dysfunction

Gut Microbial Bile and Amino Acid Metabolism Associate with Peanut Oral Immunotherapy Failure

High degree of desensitization after one year of early-life peanut oral immunotherapy – SmaChO Randomized Controlled Trial

Hospital-based challenge

Idiopathic anaphylaxis: a challenge for clinicians

IgE High-Affinity Receptor Expression as a Predictive Biomarker for Oral Immunotherapy Outcomes in Severe Egg and Milk Allergies

Immunologic profile and safety of milk oral immunotherapy in children with severe cow’s milk allergy – a series of cases

Impact of participant baseline factors on exposure-adjusted incidence of treatment-related adverse events during peanut oral immunotherapy

Induction of oral specific tolerance to cow´s milk proteins before 12 months of age – is it worth it?

Intestinal-restricted location of allergen-specific regulatory T cells is driven by oral consumption of the allergen in murine models

Intranasal Aspirin Challenge for Diagnosis of Aspirin-Exacerbated Respiratory Disease: Symptom Score Criteria and Optimal Dosage

Is milk oral immunotherapy using a home up-dosing protocol a viable and safe treatment for the older milk allergic child?

Is specific inhalation challenge still useful in the diagnosis of Baker’s asthma?

Is there still a role for oral corticosteroids in the management of CRS

Isolated Codeine Allergy with Evidence of Tolerance to Oral Morphine: A Case Report

Local allergic rhinitis in paediatric patients: prevalence and clinical outcomes in nasal allergen challenge

Long-Term Prophylactic Treatment With Oral Deucrictibant Improves Disease Control and Health-Related Quality of Life in Participants With Hereditary Angioedema in the CHAPTER-1 Open-Label Extension Study

Long-Term Safety and Efficacy of Oral Deucrictibant for Prophylaxis in Hereditary Angioedema: Data Snapshot Results of the CHAPTER-1 Open-Label Extension Study

Long-Term Safety and Efficacy of Oral Deucrictibant for Treatment of Hereditary Angioedema Attacks: Results of the RAPIDe-2 Extension Study

Long-term Follow-up After Peanut Oral Immunotherapy During Preschool Years: Lessons from the IMPACT Trial

Low dose oral immunotherapy for children with severe cow’s milk allergy

Machine Learning-Based Prediction of Desensitization Success in Oral Immunotherapy for Hen’s Egg Allergy in Children

Maintaining beta-lactam allergy delabelling in children- a challenge and an opportunity: The CHAD (CHildren Antibiotic Delabeling) follow up study

Management of Eosinophilic Esophagitis as a side effect of food oral immunotherapy

Molecular tools in support to walnut oral immunotherapy

Monitoring for early warning signs of asthma attacks and response to treatment with oral corticosteroids using the Albus Home contactless monitoring system

Monocyte chemotactic factors in the airways of patients with asthma after an allergen challenge

Multiple food protein-induced enterocolitis syndrome in a child with 8 positives oral food challenges

NOVEL MULTI-NUTS ORAL IMMUNOTHERAPY PROTOCOLS (ALPEDIA-NOITs)

Nasal allergen challenge

Navigating Oral Food and Drug Provocation Tests: Assessing Tolerance and Safety in Clinical Settings

New mechanisms for the induction of tolerance by Oral Immunotherapy

Nut Allergy in the Spotlight: The Crucial Role of Oral Provocation Tests

Omalizumab for oral desensitization in children with cow’s milk allergy

One-year follow-up of children who achieved sustained unresponsiveness following early oral immunotherapy for various allergens

Optimal Cutt-off markers for baked egg challenge

Optimising oral food challenges in IgE mediated food allergy

Oral Abstract Session 1 – Contact Dermatitis/Drug Reactions

Oral Abstract Session 2 – Atopic Dermatitis

Oral Abstract Session 25

Oral Abstract Session 26

Oral Abstract Session 27

Oral Abstract Session 28

Oral Abstract Session 29

Oral Abstract Session 3 – Urticaria/Angioedema

Oral Abstract Session 30

Oral Abstract Session 31

Oral Abstract Session 32

Oral Abstract Session 33

Oral Abstract Session 34

Oral Administration of Ginsenoside F1 Attenuates Allergic Atopic Dermatitis by Modulating T cell Activation

Oral Food Challenges in Children’s Health Ireland

Oral Immunotherapy

Oral Immunotherapy for Adults with Food Allergies

Oral Immunotherapy for Fish Allergic Children

Oral Immunotherapy with omalizumab in an adult patient with severe milk and egg allergy

Oral Mite Anaphylaxis after eating homemade Pizza with contaminated wheat flour

Oral Sebetralstat for On-demand Treatment of Hereditary Angioedema: Phase 3 KONFIDENT Trial Results

Oral allergy syndrome as a marker of food allergy in a monocentric cohort of atopic patients with eosinophilic esophagitis

Oral and skin sensitisation to peanut induce distinct immune response profiles – identification of potential biomarkers of route of sensitisation?

Oral immunotherapy (OIT) in walnut and hazelnut co-allergic patients: ELISA inhibition studies to direct treatment approach

Oral immunotherapy decreases expression of pro-inflammatory genes upon re-exposure to allergen in egg allergic children

Oral immunotherapy in cow’s milk allergic patients

Oral immunotherapy protocols for milk / egg

Oral immunotherapy to hazelnut in children: a single-center retrospective study in an Italian cohort

Oral immunotherapya for food allergy

Oral intake of food allergens promotes intestinal compartmentalization of antigen-specific regulatory T cells in mice

Outcomes of low-dose peanut food challenges in preschoolers when initiating peanut oral immunotherapy

Patterns of peanut ingestion in remission vs desensitized patients after completion of peanut oral immunotherapy at 3-years post-treatment

Peanut allergens differently adhere to oral epithelia

Peanut oral immunotherapy has not recuded basophil activation

Peanut oral immunotherapy in toddlers

Peripheral blood and urine metabolites associated with NERD after ASA challenge and long-term ASA therapy

Persisten severe cow’s milk allergy with successful oral immunotherapy in adulthood

Predicting treatment response to oral immunotherapy in peanut-allergic children using multi-omics risk scores

Predictors of response to oral immunotherapy

Prognostic value of specific IgE ratios in the tolerance of oral immunotherapy with egg allergy

Prophylactic Treatment with Oral Deucrictibant Improves Health-Related Quality of Life of Patients with Hereditary Angioedema

Protein and allergen content variability of peanut-containing products used in oral immunotherapy for peanut allergy

Protocols and outcomes in FPIES oral food challenges

Randomized controlled trial of pancake oral immunotherapy for egg allergy

Reactivity, severity and tolerance development in 50 wheat-allergic children across two oral food challenges

Real-life experience with long-term oral immunotherapy for nut allergic children: A single center study from Luxembourg

Real-world change in asthma symptom control and oral corticosteroid use in patients with severe asthma treated with mepolizumab stratified by atopic status: Post hoc analysis of REALITI-A at 2 years

Reduction in Oral Corticosteroid Burden in Patients With Moderate-to-Severe Asthma Initiating Dupilumab in the Real-World: The RAPID Registry

Retrospective evaluation of the outcome of 106 oral food challenges performed in 2017 to 2024

SEP-631: A Novel Selective and Potent Oral MRGPRX2 Inhibitor for the Treatment of Chronic Spontaneous Urticaria

Safety and Efficacy of Oral Deucrictibant for Treatment of Upper Airway and Laryngeal Hereditary Angioedema Attacks: Results from the RAPIDe-2 Extension Study

Safety and feasibility of very low dose challenge for children with egg allergies

Safety in the peach juice food challenge in LTP allergic patients

Safety of oral immunotherapy in preschool aged children with single and multiple food allergy (the ORKA trial): a prospective intervention study

Sebetralstat as Oral On-demand Treatment for Hereditary Angioedema: Interim Analysis of Demographics and Attack Characteristics from the Open-label KONFIDENT-S Trial

Slow oral immunotherapy for food allergy – what evidence do we have?

Small Doses, Big Benefits: The Promise of Low-Dose Oral Immunotherapy

Starting with Low-Dose Sesame Food Challenges for Oral Immunotherapy

Sting challenge test

Surfactants in oral care products may exacerbate Eosinophilic Esophagitis by disrupting epithelial barriers and triggering pro-inflammatory responses

The Bacterial Lysate 0M-85BV reduces risk for exacerbations and oral corticosteroids in allergic asthma: A retrospective parallel group-controlled study

The Feasibility and Applicability of Pediatric Inpatient Beta Lactam De-Labeling: From Bedside Challenge to Follow Up on Patient Chart Documentation

The Role of Oral Food Challenges in Clinical Trials: Necessity or Redundancy?

The Sting Challenge Test: a key tool for monitoring the effectiveness of venom immunotherapy

The challenge of chronic urticaria management

The challenge of drug allergy: A revised nomenclature for allergic diseases is required

The change in quality of life of adults with food allergy treated with oral immunotherapy

The overall diet and environmental factors in oral immunotherapy

The role of Innate Lymphoid Cells in food allergy and oral tolerance

The role of skin testing, serum IgE, and extended oral challenges in diagnosing childhood beta-lactam allergy: The CHildren Antibiotic Delabeling (CHAD) study

Thresholds for microbiome-dependent oral tolerance

Timing in oral immunotherapy : Early vs. Late introduction

Tolerance induction through oral immunotherapy

Tolerance to intravenous sodium heparin despite a positive subcutaneous challenge test: A case report

Transepidermal water loss: a novel predictor for food challenge outcomes

Treating Anaphylaxis: The challenge from the patient perspective

Treatment of HAE Attacks with Anticipated Future Oral On-demand Therapies as Reported by Patients

Two-year Outcomes of Low-dose Oral Immunotherapy for Children with Severe Walnut Allergy

Unmasking Mite Anaphylaxis – a Hidden Oral Allergen

Urinary PGDM is not elevated during oral food challenges for food protein-induced enterocolitis syndrome

Use of Dupilumab as Adjuvant Treatment in Oral Food Desensitization: A Case Report

Utility of conjunctival allergen challenge in the diagnosis of patients with different phenotypes of allergic rhinitis and conjunctival symptoms

Utility of peak flow in interpreting subjective chest tightness during food challenge

5-year patient-reported outcomes after oral immunotherapy using heat-modified peanuts: results from the BOPI (Boiled Peanut Oral Immunotherapy) study

Anaphylaxis to Beta-Lactams: The Importance of the Oral Challenge Test in Diagnosis

Anaphylaxis with omeprazole presenting positive oral challenge to esomeprazole

Antigen-specific IgE antibody levels as negative predictors of oral food challenge with cow’s milk in children with cow’s milk allergy

Development of standardised challenge meals to meet regulators demands for Oral Food Challenges

Do sIgE predict the oral food challenge outcomes in children with fish allergy?

Early Use Of Intravenous Methylprednisolone Attenuates Positive Challenge Reactions During Sequential Additive Drug Challenge

Evaluation of the Oral Food Challenge Test Using Baked Milk and Baked Egg in Children with Allergies to Small Amounts of Cow’s Milk or Cooked Hen’s Egg

FERMAH-OIT: Food Extensive Rapid Multi-Allergen Home Oral Immunotherapy; A novel OIT protocol without OmalizumabFERMAH-OIT: Food Extensive Rapid Multi-Allergen Home Oral Immunotherapy; A novel OIT protocol without Omalizumab

Factors associated with severity of reactions during oral food challenge test

Graded oral challenge to delabel suspected non-steroidal anti-inflammatory drugs (NSAIDs) hypersensitivity in children

High degree of sustained unresponsiveness and safety after three years of slow up-dose peanut oral immunotherapy in toddlers – results from the SmaChO study (Small Children Oral Immunotherapy)

Increase in maximum tolerated dose and decrease in symptom severity during food challenge in a clinical trial of oral immunotherapy for peanut allergy in children aged 1 to 3 years

Management of fish allergy based on Oral Food Challenge

No more restrictive diets for LTP allergic patients. The importance of oral food challenge

Nut allergy: the importance of molecular diagnosis and oral food challenge testing

Oral Challenge Tests in an Outpatient Clinic: Is It Safe?

Oral Food Challenge Approaches in Food Protein-Induced Enterocolitis Syndrome: A Systematic Review

Oral food Challenge in Adults

Oral food challenge materials and protocols

Oral food challenge outcomes in a pediatric allergy outpatient office of a tertiary hospital

Patient-reported outcomes after 5 years of oral immunotherapy for peanut allergy: results from the BOPI (Boiled Peanut Oral Immunotherapy) study

ROCI-OIT: Rapid Oral Continuous Infusion – Oral Immunotherapy; A Breakthrough methodology in the science of OIT

Risk Factors for Anaphylaxis in Food-Allergic Children During Oral Food Challenge Tests

Staggered oral peanut challenge with regular consumption at home

The Efficacy and Safety of Stepwise Oral Food Challenge in Children with Hen’s Egg Allergy

The Utility of Predicting Outcomes by Considering Intake Amount and Antigen-Specific IgE Levels in Oral Food Challenge Tests

Welcome

Only match titles

What are you looking for?

Knowledge Hub

Website

Only match titles

What are you looking for?

Knowledge Hub

Event Resources

Sponsored Symposia

Task Forces

Patient Resources

Website

Sessions

Annual Congress

Focused Meetings